Fundraising FoxBiotech Startups
10,887 companies tagged Biotech, with their investors and founders.
Endolith develops biological intelligence technology for mineral recovery, using microbiology and AI to extract critical minerals sustainably. The company serves mining operations and the clean energy supply chain.
10 investors
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair. The company translates tissue engineering research into therapeutic products for orthopedic and surgical applications.
10 investors
GALY develops biocrafted alternatives to conventionally extracted materials like cocoa and cotton, positioning grown products as sustainable replacements for industries reliant on extractive supply chains.
10 investors
Bristol Myers Squibb is a biopharmaceutical company that develops and delivers medicines across oncology, hematology, neuroscience, immunology, and cardiovascular disease areas. The company focuses on creating transformative treatments for patients in high-need therapeutic categories.
10 investors
Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options. The company focuses on addressing unmet medical needs in the rare disease space.
10 investors
Heartflow provides an AI-based analysis that converts a coronary CTA scan into a personalized 3D model of the heart, assessing anatomy and physiology to help diagnose and manage coronary artery disease (CAD). Its platform, Heartflow One, is used by cardiologists and clinicians to guide diagnosis and treatment decisions for patients.
10 investors
Helus Pharma is a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS conditions such as depression, anxiety, schizophrenia, and bipolar disorder. It focuses on advancing novel treatments for mental health disorders through clinical development and commercialization.
10 investors
10 investors
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
10 investors
Koniku develops co-processors built from biological neurons, using DNA sequences to create receptors that enable sensing applications. Its uses include detecting threats for airport security, drones for identifying buried IEDs, and taste-sensitive devices for quality assurance.
10 investors
Kopra Bio develops cancer immunotherapy technology that converts cancer cells into biofactories to produce their own destruction. The company operates in the biotech and cancer treatment space.
10 investors
Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases. It uses AAV-mediated gene therapy approaches across metabolic, neurodegenerative, and other disease areas.
10 investors
Kula Bio develops bacterial propagation and feeding systems that enhance the nitrogen-fixing capabilities of naturally occurring microbes for agricultural applications. The company applies microbial technology originally derived from bionic leaf research to improve crop and turf production.
10 investors
Luminate develops medical device technology to address chemotherapy side effects, particularly hair loss and peripheral neuropathy, for oncology patients and healthcare providers. The company is advancing clinical-stage devices while supporting cancer patients, clinicians, and health systems.
10 investors
Manus Bio uses industrial biotechnology and engineered microbial cell factories to produce "BioAlternatives" — sustainable versions of molecules normally sourced from petrochemicals, agriculture, or animal husbandry — and offers a scale-up platform covering cell factory design through biomanufacturing. Its products include sweeteners and flavor/fragrance ingredients supplied to food and consumer goods companies such as Tate & Lyle and Givaudan.
10 investors
Monarch is a personal finance app for individuals, couples, and families that connects bank accounts, credit cards, loans, and investments into one view for budgeting, tracking spending, monitoring subscriptions, and setting savings goals. It works across web, iOS, and Android and lets users collaborate with a partner or financial advisor.
10 investors
Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
10 investors
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications. The company translates bioelectronic devices from preclinical research toward first-in-human studies and commercialization.
10 investors
Osmind is a public benefit corporation developing technology and research infrastructure to accelerate evidence-based mental health treatments, including therapies like ketamine, and to improve patient access to care.
10 investors
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
10 investors
Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery. The company aims to accelerate pharmaceutical development and reduce clinical trial failure rates through human-first biological prediction models.
10 investors
ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies. The platform targets autoimmune disease, oncology, and therapeutic protein replacement applications.
10 investors
RayzeBio develops radiopharmaceutical therapies for cancer treatment. The company is a subsidiary of Bristol Myers Squibb focused on advancing targeted cancer therapies to patients.
10 investors
ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs. The company is focused on rare genetic conditions including cystic fibrosis and primary ciliary dyskinesia.
10 investors